A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2006
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	US20060257413 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/16/2006	US20060257329 Delivery of drug esters through an inhalation route
11/16/2006	DE102005061948A1 Verbessertes Verfahren zur Herstellung von 4'-O-Methylpyridoxin- und/oder Biflavon-armen Ginkgoextrakten An improved process for the preparation of 4'-O-Methylpyridoxin- and / or biflavone poor Ginkgo extracts
11/16/2006	DE102005022276A1 Derivate von Dihydroxyphenylalanin Derivatives of dihydroxyphenylalanine
11/16/2006	DE102005022182A1 Modulatoren der PDZ-Domäne Modulators of the PDZ domain
11/16/2006	CA2608249A1 Method for the treatment of drug abuse with flibanserin
11/16/2006	CA2608184A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	CA2607933A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1)
11/16/2006	CA2607802A1 Pharmaceutical formulation of apomorphine for buccal administration
11/16/2006	CA2607639A1 Crystal of indole derivative having piperidine ring and process for production thereof
11/16/2006	CA2607198A1 Dihydroxyphenylalanine derivatives
11/16/2006	CA2604624A1 Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
11/16/2006	CA2604600A1 Pregabalin free of isobutylglutaric acid and a process for preparation thereof
11/16/2006	CA2604052A1 Methods and compositions for the treatment of cns-related conditions
11/15/2006	EP1722233A2 Screening method for different indications comprising BNPI and/or DNPI
11/15/2006	EP1721903A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
11/15/2006	EP1721613A1 Hesperidin for the treatment of epilepsy, migraine, schizophrenia, depression and drug abuse
11/15/2006	EP1721610A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
11/15/2006	EP1721609A2 Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases
11/15/2006	EP1720909A2 Anti-abeta antibody
11/15/2006	EP1720891A1 Crystalline forms of a pharmaceutical compound
11/15/2006	EP1720878A1 Heteroaryl-fused pyrazolo derivatives
11/15/2006	EP1720874A1 4-substituted piperidine derivatives
11/15/2006	EP1720871A1 3,5-disubstituted 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors
11/15/2006	EP1720860A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists
11/15/2006	EP1720850A1 Coumarin derivative and use thereof
11/15/2006	EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1720844A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
11/15/2006	EP1720837A1 Derivatives of n-' (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity
11/15/2006	EP1720836A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo [d]azepines as 5-ht2c receptor agonists
11/15/2006	EP1720610A1 Alcohol metabolism moderating composition
11/15/2006	EP1720548A1 Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents
11/15/2006	EP1720547A1 Use of gaboxadol for treating insomnia
11/15/2006	EP1720544A1 Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same
11/15/2006	EP1720541A1 Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites
11/15/2006	EP1646391B1 Use of 2h-[1,3]-oxazino[3,2-a]indole derivatives for the treatment of neuropathic pain
11/15/2006	EP1646387B1 Use of indazole derivatives for the treatment of neuropathic pain
11/15/2006	EP1633334B1 Topical administration of vasoactive vitamin b3 compounds for promoting sleep
11/15/2006	EP1562945B1 1,4-diazabicyclo(3,2,2)nonane derivatives, preparation and therapeutical use thereof
11/15/2006	EP1453511B1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
11/15/2006	EP1411881B9 5ht2c receptor modulators
11/15/2006	EP1406899B1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/15/2006	EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006	EP1399143B1 Use of acetyl l-carnitine for the preparation of a medication to treat anhedonia
11/15/2006	EP1392692B1 (oxo-pyrazolo¬1,5a\|pyrimidin-2-yl)alkyl-carboxamides
11/15/2006	EP1389092B1 Abuse-resistant opioid dosage form
11/15/2006	EP1345942B9 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
11/15/2006	EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	EP1272197B1 Combination of lecithin with ascorbic acid
11/15/2006	EP1254659B1 Stable emulsion compositions
11/15/2006	EP1007514B1 Heterocyclic ketones as npy y5 antagonists
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	CN1864434A Wireless microphone communication system
11/15/2006	CN1863815A Polypeptides having brain disposition activity and utilization of the same
11/15/2006	CN1863811A Stable vitamin B6 derivative
11/15/2006	CN1863791A Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
11/15/2006	CN1863784A 2-naphthylimino-1,3-thiazine derivative
11/15/2006	CN1863782A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
11/15/2006	CN1863781A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
11/15/2006	CN1863527A 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands
11/15/2006	CN1861604A Crystal form of asenapine maleate
11/15/2006	CN1861590A Flavoneoid derivative and its preparation process and use
11/15/2006	CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
11/15/2006	CN1861181A Medicine for treating epilepsy and its prepn. method
11/15/2006	CN1861172A Oral medicated liquor for treating diseases and making health-care
11/15/2006	CN1861171A Method for preparing traditional Chinese medicine to treat apoplexia hemiplegia and said medicine
11/15/2006	CN1861135A External use semi-solid prepn. contg. paederia foetida, and its prepn. method
11/15/2006	CN1861134A Method for preparing injection sterile powder of paederia foetida
11/15/2006	CN1861133A Prepn. method for external use liquid prepn. contg. paederia foetida
11/15/2006	CN1861129A Prepn. method for paederia foetida fog-like prepn.
11/15/2006	CN1861116A Traditional Chinese medicine prepn. for treating anxiety disorders and depressive disorders
11/15/2006	CN1861111A Application of dripping pills contg. astragalus mongholicus and ginseng with tonifying-qi function to produce medicine for treating senile dementia
11/15/2006	CN1861083A Compound medicine for treating migraine headache
11/15/2006	CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006	CN1861076A Freeze-dried composition contg. nicergoline and its prepn. method
11/15/2006	CN1861060A Permeability nose absorption type medicine for treating and preventing senile dementia, improving learning memory faculty and regulating blood brain barrier
11/15/2006	CN1861056A Slow-releasing prepn. contg. gastrodin
11/15/2006	CN1860938A Sobering pear juice beverage and its prepn. method
11/15/2006	CN1860913A Instant synthetic compressed food granules of millet and wild plant and its processing method
11/15/2006	CN1284851C Somatic cell derived embryonic stem cell and its differentiated cell
11/15/2006	CN1284790C Cornel extractive, extracting method and use for preparing medicine and health food
11/15/2006	CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006	CN1284780C 8'4-'3-(5-fluoro-1H-indol-3-yl)propyl!-1-piperazinyl!-2-methyl-2H-1,4-benzoxazin -3(4H)-one methanesulfonate with high affinity for the dopamine D2 receptor and the seotonin reuptake site
11/15/2006	CN1284777C 5-membered heterocycles, preparation and use thereof as medicine
11/15/2006	CN1284598C Medicine for treating epilepsia
11/15/2006	CN1284590C Gastrodia tuber contained refractory headache treating formulation and its preparation technique and quality control method
11/15/2006	CN1284575C Baras camphor, chuanxiong rhizome headache treating medicine and its oral preparation and its preparing process
11/15/2006	CN1284561C Chinese medicine compound for promoting nerve regeneration
11/15/2006	CN1284536C Application of tetrodotoxin or saxitionxin and analogs thereof in preparation of general antalgic medicine application
11/15/2006	CN1284530C Compound tornado drop pills
11/15/2006	CN1284529C Compound gastrodia elata drop pills
11/15/2006	CN1284522C Dextrose and insulin fluid formulation for intravenous infusion
11/14/2006	US7135610 Mouse showing neurofibril change due to senile dementia
11/14/2006	US7135600 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis
11/14/2006	US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006	US7135572 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
11/14/2006	US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof

1 ... 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 ... 1833